BACKGROUND. Both seasonal and novel avian influenza viruses can result in severe infections requiring hospitalization. Anti-influenza antibodies (Abs) with Fc-mediated effector functions, such as Ab-dependent cellular cytotoxicity (ADCC), are of growing interest in control of influenza but have not previously been studied during severe human infections. As such, the objective of this study was to examine Fc-mediated Ab functions in humans hospitalized with influenza infection. METHODS. Serum Ab response was studied in subjects hospitalized with either pandemic H7N9 avian influenza virus in China (n = 18) or circulating seasonal influenza viruses in Melbourne, Australia (n = 16). Recombinant soluble Fc receptor dimer ELISAs, natural killer (NK) cell activation assays, and Ab-dependent killing assays with influenza-infected target cells were used to assess the Fc functionality of anti-influenza hemagglutinin (HA) Abs during severe human influenza infection. RESULTS. We found that the peak generation of Fc functional HA Abs preceded that of neutralizing Abs for both severe H7N9 and seasonal influenza infections. Subjects who succumbed to complications of H7N9 infection demonstrated reduced HA-specific Fc receptor–binding Abs (in magnitude and breadth) immediately prior to death compared with those who survived. Subjects who recovered from H7N9 and severe seasonal influenza infections demonstrated increased Fc receptor–binding Abs not only against the homologous infecting strain but against HAs from different influenza A subtypes. CONCLUSION. Collectively, survivors of severe influenza infection rapidly generate a functional Ab response capable of mediating ADCC against divergent influenza viruses. Broadly binding HA Abs with Fc-mediated functions may be a useful component of protective immunity to severe influenza infection. FUNDING. The National Health and Medical Research Council ([NHMRC] grants 1023294, 1041832, and 1071916), the Australian Department of Health, and the joint University of Melbourne/Fudan University International Research and Research Training Fund provided funding for this study.
Hillary A. Vanderven, Lu Liu, Fernanda Ana-Sosa-Batiz, Thi H.O. Nguyen, Yanmin Wan, Bruce Wines, P. Mark Hogarth, Danielle Tilmanis, Arnold Reynaldi, Matthew S. Parsons, Aeron C. Hurt, Miles P. Davenport, Tom Kotsimbos, Allen C. Cheng, Katherine Kedzierska, Xiaoyan Zhang, Jianqing Xu, Stephen J. Kent
Title and authors | Publication | Year |
---|---|---|
Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
Schwedler JL, Stefan MA, Thatcher CE, McIlroy PR, Sinha A, Phillips AM, Sumner CA, Courtney CM, Kim CY, Weilhammer DR, Harmon B |
mAbs | 2024 |
Distinct functional humoral immune responses are induced after live attenuated and inactivated seasonal influenza vaccination
Tong X, Deng Y, Cizmeci D, Fontana L, Carlock MA, Hanley HB, McNamara RP, Lingwood D, Ross TM, Alter G |
Journal of immunology (Baltimore, Md. : 1950) | 2024 |
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination
Clark J, Hoxie I, Adelsberg DC, Sapse IA, Andreata-Santos R, Yong JS, Amanat F, Tcheou J, Raskin A, Singh G, González-Domínguez I, Edgar JE, Bournazos S, Sun W, Carreño JM, Simon V, Ellebedy AH, Bajic G, Krammer F |
2024 | |
Protective Non-neutralizing anti–N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
Izadi A, Godzwon M, Söderlund Strand A, Schmidt T, Kumlien Georén S, Drosten C, Ohlin M, Nordenfelt P |
The Journal of Immunology Author Choice | 2024 |
Fc‐FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement
Edgar JE, Bournazos S |
Immunological Reviews | 2024 |
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination
Clark JJ, Hoxie I, Adelsberg DC, Sapse IA, Andreata-Santos R, Yong JS, Amanat F, Tcheou J, Raskin A, Singh G, González-Domínguez I, Edgar JE, Bournazos S, Sun W, Carreño JM, Simon V, Ellebedy AH, Bajic G, Krammer F |
Cell reports | 2024 |
Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza
Hillary Vanderven, Deborah Wentworth, Win Min Han, Heidi Peck, Ian Barr, Richard Davey, John Beigel, Dominic Dwyer, Mamta K. Jain, Brian Angus, Christian Brandt, Analia Mykietiuk, Matthew Law, Jim Neaton, Stephen Kent |
JCI Insight | 2023 |
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
Chavda VP, Bezbaruah R, Dolia S, Shah N, Verma S, Savale S, Ray S |
2023 | |
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations
Purcell RA, Theisen RM, Arnold KB, Chung AW, Selva KJ |
Frontiers in immunology | 2023 |
Understanding Fc function for rational vaccine design against pathogens
Bowman KA, Kaplonek P, McNamara RP |
mBio | 2023 |
Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence
F Fuentes-Villalobos, J Garrido, M Medina, N Zambrano, N Ross, F Bravo, A Gaete-Argel, A Oyarzún-Arrau, F Amanat, R Soto-Rifo, F Valiente-Echeverría, R Ocampo, C Esveile, L Ferreira, J Cabrera, V Torres, M Rioseco, R Riquelme, S Barría, R Alvarez, Y Pinos, F Krammer, M Calvo, M Barria |
Frontiers in immunology | 2022 |
Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV
Motsoeneng BM, Dhar N, Nunes MC, Krammer F, Madhi SA, Moore PL, Richardson SI |
Frontiers in immunology | 2022 |
Universal antibody targeting the highly conserved fusion peptide provides cross-protection in mice.
Muralidharan A, Gravel C, Harris G, Hashem AM, Zhang W, Safronetz D, Van Domselaar G, Krammer F, Sauve S, Rosu-Myles M, Wang L, Chen W, Li X |
Human Vaccines & Immunotherapeutics | 2022 |
Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection
Voronina DV, Shcheblyakov DV, Favorskaya IA, Esmagambetov IB, Dzharullaeva AS, Tukhvatulin AI, Zubkova OV, Popova O, Kan VY, Bandelyuk AS, Shmarov MM, Logunov DY, Naroditskiy BS, Gintsburg AL |
Viruses | 2022 |
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
KJ Selva, CE van de Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, SK Davis, TH Nguyen, LC Rowntree, L Hensen, M Koutsakos, CY Wong, F Mordant, DC Jackson, KL Flanagan, J Crowe, S Tosif, MR Neeland, P Sutton, PV Licciardi, NW Crawford, AC Cheng, DL Doolan, F Amanat, F Krammer, K Chappell, N Modhiran, D Watterson, P Young, WS Lee, BD Wines, PM Hogarth, R Esterbauer, HG Kelly, HX Tan, JA Juno, AK Wheatley, SJ Kent, KB Arnold, K Kedzierska, AW Chung |
Nature Communications | 2021 |
Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
MK Siggins, RS Thwaites, PJ Openshaw |
Trends in Microbiology | 2021 |
Natural killer cell activation by respiratory syncytial virus‐specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc‐glycosylation
EA Erp, AJ Lakerveld, E Graaf, MD Larsen, RM Schepp, AL Ederveen, IM Ahout, CA Haan, M Wuhrer, W Luytjes, G Ferwerda, G Vidarsson, PB Kasteren |
IBMS BoneKEy | 2020 |
Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function
R Gao, Z Sheng, CC Sreenivasan, D Wang, F Li |
Viruses | 2020 |
Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response
S Pierce, ES Geanes, T Bradley |
Frontiers in Cellular and Infection Microbiology | 2020 |
Vaccination with ADCC activating HA peptide epitopes provides 1 partial protection from influenza infection
N Kavian, A Hachim, LL Poon, SA Valkenburg |
Vaccine | 2020 |
Potential benefits, mechanisms, and uncertainties of convalescent plasma therapy for COVID-19
W Dai, H Gu, S Hao |
2020 | |
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
EA van Erp, W Luytjes, G Ferwerda, PB van Kasteren |
Frontiers in immunology | 2019 |
Cross‐reactive antibody‐dependent cellular cytotoxicity antibodies are increased by recent infection in a household study of influenza transmission
SA Valkenburg, VJ Fang, NH Leung, DK Chu, DK Ip, RA Perera, Y Wang, AP Li, JS Peiris, BJ Cowling, LL Poon |
IBMS BoneKEy | 2019 |
Influenza and Antibody-Dependent Cellular Cytotoxicity
TA Holle, MA Moody |
Frontiers in immunology | 2019 |
DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response
M Zhong, H Wang, L Ma, H Yan, S Wu, Z Gu, Y Li |
Virology Journal | 2019 |
Boosting of Markers of Fcγ Receptor Function in Anti-HIV Antibodies During Structured Treatment Interruption
H Billings, BD Wines, WB Dyer, RJ Center, HM Trist, SJ Kent, PM Hogarth |
AIDS Research and Human Retroviruses | 2019 |
Improving immunological insights into the ferret model of human viral infectious disease
J Wong, D Layton, AK Wheatley, SJ Kent |
Influenza and Other Respiratory Viruses | 2019 |
The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine
SA Valkenburg, NH Leung, MB Bull, L Yan, AP Li, LL Poon, BJ Cowling |
Frontiers in immunology | 2018 |
The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine
S Jegaskanda |
Human vaccines | 2018 |
Anti-influenza Hyperimmune Immunoglobulin Enhances Fc-functional Antibody Immunity during Human Influenza Infection
HA Vanderven, K Wragg, F Ana-Sosa-Batiz, AB Kristensen, S Jegaskanda, AK Wheatley, D Wentworth, BD Wines, PM Hogarth, S Rockman, SJ Kent |
The Journal of Infectious Diseases | 2018 |
Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia
BD Wines, CW Tan, E Duncan, S McRae, RI Baker, RK Andrews, S Esparon, EE Gardiner, PM Hogarth |
Journal of Thrombosis and Haemostasis | 2018 |
Prospects from systems serology research
KB Arnold, AW Chung |
Immunology | 2017 |